Your browser doesn't support javascript.
loading
Efficacy and Safety of Ombitasvir plus Paritaprevir, Ritonavir and Ribavirin in Non-cirrhotic Treatment-naïve and Treatment-experienced Egyptians with Chronic HCV Genotype-4 Infection.
Ahmed, Manar; Mansey, Azza E; Wahsh, Engy A; Gomaa, Ahmed A; Rabea, Hoda M.
Afiliação
  • Ahmed M; Department of Clinical Pharmacy, Faculty of Pharmacy, Beni Suef University, Beni Suef, 62521, Egypt.
  • Mansey AE; Department of Clinical Pharmacy, Faculty of Pharmacy, Menoufia University, Al Menoufia, 32511, Egypt.
  • Wahsh EA; Department of Clinical Pharmacy, Faculty of Pharmacy, October 6 university, Giza, 12573, Egypt. engywahsh@o6u.edu.eg.
  • Gomaa AA; Department of Tropical Medicine, Faculty of Medicine, Fayoum University, Fayoum, 63511, Egypt.
  • Rabea HM; Department of Clinical Pharmacy, Faculty of Pharmacy, Beni Suef University, Beni Suef, 62521, Egypt.
Curr Med Sci ; 41(3): 581-586, 2021 Jun.
Article em En | MEDLINE | ID: mdl-34047942

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Ribavirina / Sulfonamidas / Valina / Prolina / Ritonavir / Hepatite C Crônica / Ciclopropanos / Lactamas Macrocíclicas / Anilidas Tipo de estudo: Guideline / Risk_factors_studies Limite: Adult / Female / Humans / Male Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Ribavirina / Sulfonamidas / Valina / Prolina / Ritonavir / Hepatite C Crônica / Ciclopropanos / Lactamas Macrocíclicas / Anilidas Tipo de estudo: Guideline / Risk_factors_studies Limite: Adult / Female / Humans / Male Idioma: En Ano de publicação: 2021 Tipo de documento: Article